Abbott Just Made a Big Bet on Cancer Screening Abbott Laboratories (ABT) just finalized its $23 billion acquisition of Exact Sciences. Learn how this deal expands its diagnostic reach. By Tyler Jarman | March 25, 2026 Read this issue
Engineering & Construction stocks display incredible relative strength in a weak market Engineering & Construction stocks surge, semis stay strong on AI spending, and financials flash warning signs. Here’s what it means for markets now. By Brian Hunt | March 23, 2026 Read this issue
A stock at the nexus of the robotics boom and the U.S. manufacturing boom is soaring A robotics and manufacturing stock surges, AI demand could spark another rally, and power grid plays keep climbing as major trends accelerate. By Brian Hunt | March 10, 2026 Read this issue
Moderna Stock (MRNA) Is Down 90%. Here’s Why the Next 90% Move Is Up. Moderna stock has plunged 90%, but its cancer vaccine pipeline, strong cash position, and mRNA platform could fuel a powerful comeback. By Thomas Yeung | February 27, 2026 Read this issue
How AI’s soaring power demands can make you money Discover how AI’s soaring power demands are creating investment opportunities in energy and solar markets, and learn strategies to profit from rising electricity needs driven by AI infrastructure growth. By Brian Hunt | February 18, 2026 Read this issue
Top 4 Cannabis Stocks to Watch in 2026 as Trump Reshapes Marijuana Policy Trump's marijuana rescheduling push and the 2026 Hemp Cliff are reshaping cannabis stocks. Here are the top names investors are watching. By David Engle | February 10, 2026 Read this issue